Natera Inc. News
Latest updates and market news for NTRA
17 news
Feb 23 - Mar 1, 2026
Page 1
MT Newswires
UBS Adjusts Natera Price Target to $290 From $280, Maintains Buy Rating
📈
AI Sentiment
Highly Positive
8/10
Business Wire
Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation
📈
AI Sentiment
Highly Positive
8/10
GuruFocus.com
Natera Inc (NTRA) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook ...
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
Natera, Inc. (NTRA) Announces Results From the SINERGY Trial
📈
AI Sentiment
Highly Positive
9/10
Zacks
Natera (NTRA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
📈
AI Sentiment
Highly Positive
9/10
StockStory
Natera Earnings: What To Look For From NTRA
MT Newswires
Natera's Phase 2 Trial Shows ctDNA-Guided Therapy Reduces Chemo in Head and Neck Cancer
➖
AI Sentiment
Neutral
5/10
Business Wire
Successful Readout of Prospective Phase 2 SINERGY Trial Supports SignateraTM MRD-Guided Treatment in Head and Neck Cancer
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Is Natera (NTRA) Fairly Priced After Recent Share Price Pullback?
➖
AI Sentiment
Neutral
5/10
Zacks
Unveiling Natera (NTRA) Q4 Outlook: Wall Street Estimates for Key Metrics
📉
AI Sentiment
Negative
2/10
Share this news page